Trump Announces Weight-Loss Drug Price Negotiations, Lilly Stocks Fall
Shares of Eli Lilly and Novo Nordisk fell Friday, Oct. 17 after Pres. Donald Trump said the price of the weight-loss drug Ozempic could soon drop to $150 a month.
Read MoreShares of Eli Lilly and Novo Nordisk fell Friday, Oct. 17 after Pres. Donald Trump said the price of the weight-loss drug Ozempic could soon drop to $150 a month.
Read MoreOne of the nation’s largest real estate companies has transferred its corporate registration back to Indiana from the state of Delaware, in what Indiana Secretary of State Diego Morales has dubbed a “big win.”
Read MoreIndiana has poured almost $1 billion into a contentious technology park with few tenants and a mystery budget, reporters with the Arnolt Center for Investigative Journalism and the Indiana Capital Chronicle have found.
Read MoreTo fight cheaper alternative versions of its weight loss drug, Eli Lilly & Co. have lowered prices of Zepbound vials.
Read More